Oramed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -19,619 | 9,212 | 1,536 | 13,336 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,106 | 2,076 | -1,478 | -1,421 |
Cash | 42,104 | 84,753 | 18,576 | 9,055 |
Basic Shares | 40,209 | 40,628 | 40,519 | 40,338 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,340 | $2,703 | $2,703 | $2,710 |
Gross Profit | 2,703 | 2,703 | 2,620 | |
EBITDA | -36,976 | -25,039 | -11,312 | |
EBIT | -40,598 | -25,116 | -11,319 | |
Net Income | 5,525 | -37,764 | -22,238 | -11,511 |
Net Change In Cash | 1,340 | 2,703 | 2,703 | 2,710 |
Free Cash Flow | -10,549 | -28,414 | -21,556 | -12,522 |
Cash | 9,055 | 40,464 | 77,245 | 19,296 |
Basic Shares | 40,338 | 38,997 | 28,469 | 20,532 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.48 |
2024-06-30 | $0.26 |
2024-05-31 | $0.04 |
2024-03-31 | $0.04 |
